CoVICIS News
CoVICIS Newsletter September 2023
Launched in early 2022, CoVICIS represents a global approach to combatting the SARS-CoV-2 pandemic, coupling powerful state-of-the-art virologic and immunologic platforms with large genomic surveillance studies and diverse cohorts in Europe and sub-Saharan Africa (SSA).
CoVICIS in context: surveillance and Switzerland with Prof. Milo Puhan, MD, Ph.D., University of Zurich
Professor Puhan joins us to discuss the three prospective cohort studies, including children, adolescents, and adults, based at EBPI that are contributing to the CoVICIS project.
Interview with Giuseppe Pantaleo, Horizon Magazine
Professor Giuseppe Pantaleo spoke with Vittoria D’Alessio from Horizon Magazine to discuss the ongoing work of researchers to monitor populations for new variants of concern. The article features a profile of CoVICIS and the EU-funding COVIRNA project which is devising a test to predict who is most likely to develop cardiovascular complications.
CoVICIS Newsletter November 2022
Launched in early 2022, CoVICIS represents a global approach to combatting the SARS-CoV-2 pandemic, coupling powerful state-of-the-art virologic and immunologic platforms with large genomic surveillance studies and diverse cohorts in Europe and sub-Saharan Africa (SSA).
CoVICIS in context: surveillance and South Africa with Prof. Carolyn Williamson, Ph.D., University of Cape Town
Prof Williamson joins us to discuss the impressive surveillance work being conducted in South Africa and some of the insights into future work to investigate the role of the HIV epidemic in the emergence of variants of concern.
CoVICIS is funded by the European Union’s Horizon Europe Research and Innovation Programme under grant nr 101046041